Skip to main content
. 2014 May 30;15:63. doi: 10.1186/1471-2350-15-63

Table 1.

Rare gene variants identified in the “independent PS control group”

Gene Position (hg19) Ref Alt MAF Variants dbSNP id Freq Pathogenicity
GERP POLYPHEN2 prediction
HRASLS5
chr11:63,230,659
G
C
0.040
Intron_variant
rs2282479
0.017
1.14
Unknown
HRASLS5
chr11:63,233,710
A
G
0.189
Leu207Leu
rs2275999
0.100
4.16
Unknown
HRASLS5
chr11:63,256,441
C
G
0.207
Ala93Pro
rs940611
0.033
−1.03
Benign (0.000)
HRASLS5
chr11:63,258,424
C
T
unknown
Arg28Gln
unknown
0.017
−5.14
Poss-dam (0.897)
LGALS12
chr11:63,276,480
G
A
0.023
Intron_variant
rs200256001
0.033
−2.69
Unknown
LGALS12
chr11:63,277,334
A
G
0.009
Ile176Val
rs117587231
0.017
4.42
Benign (0.005)
LGALS12
chr11:63,278,621
C
G
0.333
Intron_variant
rs2239679
0.200
−0.07
Unknown
PLA2G16 chr11:63,381,458 C T 0.072 Intron_variant rs61929725 0.150 −5.26 Unknown

Variant location is reported using hg19 coordinates. MAF, minor allele frequency according to the NCBI dbSNP137 database; Freq, frequency of the variant allele in the cohort of 30 patients; GERP, Genomic Evolutionary Rate Profiling; the POLYPHEN2 measures of pathogenicity are: Benign, possibly damaging (Poss-dam), and probably damaging based on the false discovery rate.